BREAKING NEWS | Long COVID May Be Prevented with an Antiviral
This research concludes that ANTIVIRALS reduced the risk of developing Long COVID and should be recommended to treat an acute COVID infection ....
BREAKING NEWS
Drugs | Pharmaceuticals
Latest Research | Long Covid
BREAKING NEWS
Canada & Long Covid
Latest Research | Long Covid
Long Covid Worldwide
ME/CFS
BREAKING NEWS | Long COVID Risk Decreases as the Pandemic Progresses
They looked at the pre-delta, delta and omicron eras of infection with SARS-CoV-2 and showed that the risk of Long COVID decreased over the course of the pandemic from 10% to 8% in unvaccinated persons. The results of this trial have been talked about on social media with a lot of disappointment as Paxlovid didn’t
Biomarkers
BREAKING NEWS
Latest Research | Long Covid
BREAKING NEWS: Visual Imaging Detects Remnants of SARS-CoV-2
A study on long Covid patients revealed persistent immune activation and potential virus presence in various organs even years after infection. The research utilized imaging techniques to identify immune activation in the brain, spinal cord, lungs, and gut wall. The findings suggest a need for further investigation into treatments targeting leftover virus and immunomodulating therapies....
Latest Research | Long Covid
News
NEWS: Speeding up Long Covid Treatments
A news article discusses the shift towards decentralized clinical trials (DCTs) for long COVID treatments, enabling patients to participate from home rather than traveling to clinical sites.....
BREAKING NEWS
Drugs | Pharmaceuticals
Latest Research | Long Covid
ME/CFS
BREAKING NEWS | PAXLOVID DIDN’T Work for Long Covid Treatment
This is the first Paxlovid trial out looking at whether Paxlovid would work for Long COVID treatment with the thinking that if the theory of a viral reservoir, or viral persistence is causing the illness then a drug that reduces the virus should help reduce the symptoms. The results of this trial have been talked
BREAKING NEWS
Latest Research | Long Covid
BREAKING NEWS | US National Academies Long Covid Report
Diagnosing, measuring, and treating Long COVID is complicated, as it can present differently from person to person and persist for months or years
Cardiovascular Respiratory Issues
Latest Research | Long Covid
Cardiovascular Considerations in the Management of People With Suspected Long COVID
Functional limitations and cardiovascular symptoms in long COVID. This research focuses on investigating long COVID, particularly the cardiovascular symptoms and functional limitations associated with the condition.
Brain Fog | Cognitive functioning
Latest Research | Long Covid
Neurological Effects of Long Covid
Long Covid linked to Lasting Cognitive Issues
A recent study published in Brain reveals that individuals suffering from long-term COVID-19 may experience significant cognitive issues for over a year. Conducted during the first wave of the pandemic, the research compared patients with ongoing symptoms to those who had fully recovered. Read More...
Cardiovascular Respiratory Issues
Latest Research | Long Covid
Viruses Cause Cardiomyopathy through Inflammatory Processes
Viral ARDS promotes cardiac inflammation by expanding the CCR2+ macrophage subset, and the associated cardiac phenotypes in mice can be elicited by activating the host immune system even without viral presence in the heart. Read Research..
Kids | Pediatrics
Kids Long Covid
Kids Symptom Relief | Management
Research | Education
**Long Covid in Kids
Long Covid symptoms in children can vary widely and may persist for weeks or even months after the initial infection. While some children may recover fully within a few weeks, others continue to experience lingering effects that impact their daily lives.